Share This Author
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular…
Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance
Gadolinium CMR is a powerful technique to distinguish DCM from LV dysfunction related to CAD and yields new insights in DCM, and may become a useful alternative to routine coronary angiography in the diagnostic workup of DCM.
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR)…
- D. Messroghli, J. Moon, M. Friedrich
- Medicine, BiologyJournal of Cardiovascular Magnetic Resonance
- 9 October 2017
This document provides a summary of the existing evidence for the clinical value of parametric mapping in the heart as of mid 2017, and gives recommendations for practical use in different clinical scenarios for scientists, clinicians, and CMR manufacturers.
Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans
A robust and noninvasive technique, equilibrium contrast CMR (EQ–CMR), is developed and validated to measure diffuse myocardial fibrosis as an add-on to a standard CMR scan, which allows for the nonin invasive quantification of the diffuse fibrosis burden in myocardIAL diseases.
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Bone scintigraphy enables the diagnosis of cardiac ATTR amyloidosis to be made reliably without the need for histology in patients who do not have a monoclonal gammopathy, and proposes noninvasive diagnostic criteria that are applicable to the majority of patients with this disease.
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
- J. Moon, D. Messroghli, E. Schelbert
- MedicineJournal of Cardiovascular Magnetic Resonance
- 14 October 2013
This document provides recommendations for clinical and research T1 and ECV measurement, based on published evidence when available and expert consensus when not, and addresses controversies in the field.
Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance
Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and…
Ventricular Fibrosis Suggested by Cardiovascular Magnetic Resonance in Adults With Repaired Tetralogy of Fallot and Its Relationship to Adverse Markers of Clinical Outcome
RV and LV LGE were common after TOF repair and were related to adverse clinical markers, including ventricular dysfunction, exercise intolerance, and neurohormonal activation, and furthermore, RV LGE was significantly associated with clinical arrhythmia.